Tessara Therapeutics, a pioneering biotech start-up based in Melbourne, has developed a platform which creates 3D human brain models using stem cells. Its RealBrain technology generates reproducible, scalable micro-tissues that mimic the complexity of the human brain. Ready to accelerate neural drug discovery – without using animal models. From working with CSIRO’s Kickstart program, receiving a CRC-P grant with Xylo Bio, and the University of Sydney to develop neuroplastogens to resear...
All content for The MTPConnect Podcast is the property of MTPConnect and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Tessara Therapeutics, a pioneering biotech start-up based in Melbourne, has developed a platform which creates 3D human brain models using stem cells. Its RealBrain technology generates reproducible, scalable micro-tissues that mimic the complexity of the human brain. Ready to accelerate neural drug discovery – without using animal models. From working with CSIRO’s Kickstart program, receiving a CRC-P grant with Xylo Bio, and the University of Sydney to develop neuroplastogens to resear...
One of the challenges we face in Australia is getting more homegrown medtech products purchased and used by local hospitals and health services. MTPConnect’s Pathway to Market – Medtech Capability Uplift Program has been supporting ten market-ready Victorian medtech manufacturers to position themselves competitively for local health procurement opportunities. The recent Australian Medtech Manufacturing Alliance (AMMA) Medtech Showcase profiled Victorian-made products and innovatio...
The MTPConnect Podcast
Tessara Therapeutics, a pioneering biotech start-up based in Melbourne, has developed a platform which creates 3D human brain models using stem cells. Its RealBrain technology generates reproducible, scalable micro-tissues that mimic the complexity of the human brain. Ready to accelerate neural drug discovery – without using animal models. From working with CSIRO’s Kickstart program, receiving a CRC-P grant with Xylo Bio, and the University of Sydney to develop neuroplastogens to resear...
